3 ms·
har har. Except I work in industry, both specialty and retail pharmacies. For any chronic disease (the ones this program benefits most), most doctors will get
by bearjaws 4y ago
har har.
Except I work in industry, both specialty and retail pharmacies.
For any chronic disease (the ones this program benefits most), most doctors will get you setup with the cheapest option for your insurance / PBM. As cost of treatment is the #4 indicator whether people will fall off treatment in the United States[1]. Additionally, in a retrospective study, cost was cited as the main reason for non-adherence in 17% of cases, making it the #3 leading cause[2]. This number is as high as 55% depending on age / demographic... Doctors working in chronic diseases know this and have to deal with it like any other adherence issue.
For one off treatments, people usually just go to their grocery store or local pharmacy.
Are there patients who are over paying? Absolutely. Is this a cash grab by a multi-billionaire because its not actually addressing the issues resulting in expensive drugs? Absolutely.
[1] adherence to refills and medications scale
[2]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934668/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934668/
- yunohn 4y agoYour response is quite confusing. On one hand, you’re proving my point that consumers are overpaying regularly. Medicine prices are a meme at this point, and if it were easily solved we wouldn’t hear about it as leading causes for non-adherence. > Are there patients who are over paying? Absolutely But then, you dismiss all of that by implying this is a useless exercise because patients who need low cost meds are getting them. Which one is it?